Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study

Lancet Diabetes and Endocrinology,The - Tập 10 - Trang 571-580 - 2022
Carmen Piernas1,2, Martina Patone1, Nerys M Astbury1,3, Min Gao1, Aziz Sheikh4, Kamlesh Khunti5, Manu Shankar-Hari6, Sharon Dixon1, Carol Coupland1,7, Paul Aveyard1,3, Julia Hippisley-Cox1, Susan A Jebb1,3
1Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK
2Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Center for Biomedical Research, University of Granada, Granada, Spain
3NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
4Usher Institute, University of Edinburgh, Edinburgh, UK
5Diabetes Research Centre, University of Leicester, Leicester, UK
6Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
7School of Medicine, University of Nottingham, Nottingham, UK

Tài liệu tham khảo

Clark, 2020, Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study, Lancet Glob Health, 8, e1003, 10.1016/S2214-109X(20)30264-3 Földi, 2020, Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis, Obes Rev, 21, 10.1111/obr.13095 Huang, 2020, Obesity in patients with COVID-19: a systematic review and meta-analysis, Metabolism, 113, 10.1016/j.metabol.2020.154378 Popkin, 2020, Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships, Obes Rev, 21, 10.1111/obr.13128 Gao, 2021, Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study, Lancet Diabetes Endocrinol, 9, 350, 10.1016/S2213-8587(21)00089-9 Williamson, 2020, Factors associated with COVID-19-related death using OpenSAFELY, Nature, 584, 430, 10.1038/s41586-020-2521-4 Seidu, 2020, The impact of obesity on severe disease and mortality in people with SARS-CoV-2: a systematic review and meta-analysis, Endocrinol Diabetes Metab, 4 Sanchis-Gomar, 2020, Obesity and outcomes in COVID-19: when an epidemic and pandemic collide, Mayo Clin Proc, 95, 1445, 10.1016/j.mayocp.2020.05.006 Honce, 2019, Impact of obesity on influenza A virus pathogenesis, immune response, and evolution, Front Immunol, 10, 10.3389/fimmu.2019.01071 Green, 2017, Obesity impairs the adaptive immune response to influenza virus, Ann Am Thorac Soc, 14, S406, 10.1513/AnnalsATS.201706-447AW Ball, 2019, How I ventilate an obese patient, Crit Care, 23, 176, 10.1186/s13054-019-2466-x Andrews, 2021, Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK, MedRxiv Neidich, 2017, Increased risk of influenza among vaccinated adults who are obese, Int J Obes, 41, 1324, 10.1038/ijo.2017.131 Paich, 2013, Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus, Obesity (Silver Spring), 21, 2377, 10.1002/oby.20383 Sheridan, 2012, Obesity is associated with impaired immune response to influenza vaccination in humans, Int J Obes, 36, 1072, 10.1038/ijo.2011.208 Baden, 2021, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, N Engl J Med, 384, 403, 10.1056/NEJMoa2035389 Polack, 2020, Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577 Whitaker, 2022, Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups, J Infect, 84, 675, 10.1016/j.jinf.2021.12.044 Weir, 2020 Townsend, 1987 Hippisley-Cox, 2021, Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study, BMJ, 374 Jackson, 2013, The test-negative design for estimating influenza vaccine effectiveness, Vaccine, 31, 2165, 10.1016/j.vaccine.2013.02.053 Verani, 2017, Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls, Vaccine, 35, 3295, 10.1016/j.vaccine.2017.04.037 Alban Valabhji, 2020, Early outcomes from the English National Health Service diabetes prevention programme, Diabetes Care, 43, 152, 10.2337/dc19-1425 Andrews, 2021, Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study, Medrxiv Monin, 2021, Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study, Lancet Oncol, 22, 765, 10.1016/S1470-2045(21)00213-8 Willis Painter, 2015, The weight of obesity on the human immune response to vaccination, Vaccine, 33, 4422, 10.1016/j.vaccine.2015.06.101 Hewitt, 2020, The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study, Lancet Public Health, 5, e444, 10.1016/S2468-2667(20)30146-8 Rietman, 2018, The association between BMI and different frailty domains: a U-shaped curve?, J Nutr Health Aging, 22, 8, 10.1007/s12603-016-0854-3